Sponsor Pipeline

Shenzhen TargetRx Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
9
Active Trials
4
Recruiting
2
Phase 3
8
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
2
Phase 1/2
1
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06082635 TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC) Non Small Cell Lung Cancer Active, Not Recruiting
NCT07489755 TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients Chronic Myelogenous Leukemia Not Yet Recruiting
Phase 2
NCT06453902 TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients Chronic Myeloid Leukemia Recruiting
NCT05955391 TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC) Non-small Cell Lung Cancer Active, Not Recruiting
Phase 1/2
NCT06206174 TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies Hematologic Malignancy Recruiting
Phase 1
NCT06088888 TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia Recruiting
NCT06484816 TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic… Non Small Cell Lung Cancer Recruiting
NCT05434312 TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients Chronic Myelogenous Leukemia Active, Not Recruiting
NCT05441956 TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC) Non-small Cell Lung Cancer Active, Not Recruiting
Disease Areas
Leukemia (5) Non-Small Cell Lung Cancer (NSCLC) (4) Lung Cancer (4) Acute Myeloid Leukemia (AML) (1) Acute Lymphoblastic Leukemia (ALL) (1) Non-Hodgkin Lymphoma (1) Myelodysplastic Syndromes (MDS) (1) Chronic Myeloid Leukemia (CML) (1)
Get alerts when Shenzhen TargetRx Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free